Jan 13, 2025 11:16 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis.

Jan 16, 2025 19:23 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis.

Lupin had formed a Hammer Candlestick pattern on the daily charts, and after a day of consolidation, it has resumed its upward movement. On the hourly charts, it is sustaining above the key short ...

Below are some trading ideas for the near term: After the short-term correction from higher levels, the downward momentum in Lupin has stopped around its support area. On the daily charts ...

Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung ...

Lupin is an innovation led Transnational Pharmaceutical Company producing developing and marketing a wide range of branded & generic formulations biotechnology products and active pharmaceutical ...

Lupin Ltd (BOM:500257) reports robust financial performance with significant gains in India and US markets, while navigating competitive challenges and FDA compliance issues.

Axis Securities recommends an overweight call on Lupin with a target price of Rs 2600. Lupin's current price is Rs 2160. New launches in the US are expected to boost sales. Recent approvals have ...

The releases of the hostages and around 200 prisoners were the second exchange as part of the cease-fire deal in Gaza. Israel said the four hostages, all women, were back in the country. President ...

Jan. 10, 2025 — More than half of 23-year-olds in a European study show restrictive, emotional or uncontrolled eating behaviors, according to new research. ... Climate Fee on Food Could ...